藏药治疗结核病的研究进展
Research Progress on Tibetan Medicine for the Treatment of Tuberculosis
DOI: 10.12677/acm.2024.1451556, PDF,    科研立项经费支持
作者: 倪书奕*, 何树梅#：西藏民族大学医学院藏药检测技术教育部工程研究中心，陕西 咸阳；汪中涛：西藏军区总医院感染病科，西藏 拉萨
关键词: 藏药；结核病；结核分枝杆菌；抗结核；Tibetan Medicine； Tuberculosis； Mycobacterium tuberculosis； Anti-Tuberculosis
摘要: 结核病是由结核分枝杆菌引起的一种慢性传染病，目前结核病患者数量以及耐药结核的发生率增加，使结核病临床治疗面临众多挑战。西藏地区结核病发病率较高，而在藏区可以因地制宜运用其特有的藏医药资源，通过就地取材的药物研发治疗结核病，以缓解因结核病带来的就业困难、农牧业劳动力不足和生活质量下降等相关问题，促进未来西藏社会经济发展。近年来有相关实验和临床研究表明，藏医药在抗结核病上有一定作用。本文对单味藏药和藏药复方抗结核病作用的研究现状进行综述，为今后藏药抗结核相关研究提供理论基础，同时为藏药的临床应用提供参考。
Abstract: Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (MTB). And the current increase in the number of tuberculosis patients and the incidence of drug-resistant tuberculosis has led to numerous challenges in the clinical treatment of tuberculosis. Xizang has a high incidence of tuberculosis, and the Tibetan region can make use of its unique Tibetan medicine resources in a localized manner to treat TB, through local drug development in order to alleviate the employment difficulties, labor shortage in agriculture and animal husbandry, and decline in quality of life due to TB, and to promote the social and economic development of Xizang in the future. In recent years, there have been relevant experimental and clinical studies showing that Tibetan medicine has a certain role in anti-tuberculosis. By reviewing the research of single Tibetan medicine and complex prescription of Tibetan medicine in the treatment of tuberculosis, this article aims to provide a theoretical basis for the research related to the anti-tuberculosis of Tibetan medicines, as well as to provide a reference for the clinical application of Tibetan medicines.
文章引用：倪书奕, 汪中涛, 何树梅. 藏药治疗结核病的研究进展[J]. 临床医学进展, 2024, 14(5): 1320-1328. https://doi.org/10.12677/acm.2024.1451556

参考文献

[1] World Health Organization (2023) Global Tuberculosis Report 2023. Geneva.
[2] 王前, 李涛, 杜昕, 等. 2015-2019年全国肺结核报告发病情况分析[J]. 中国防痨杂志, 2021, 43(2): 107-112.
[3] 杨国锋, 王健, 张宝莹, 等. 2008-2017年西藏自治区肺结核流行特征[J]. 中华疾病控制杂志, 2020, 24(9): 1106-1109.
[4] Djochie, R.D.A., Anto, B.P. and Opare-Addo, M.N.A. (2023) Determinants of Adverse Reactions to First-Line Antitubercular Medicines: A Prospective Cohort Study. Journal of Pharmaceutical Policy and Practice, 16, Article 70. [Google Scholar] [CrossRef] [PubMed]
[5] Dean, A.S., Tosas Auguet, O., Glaziou, P., et al. (2022) 25 Years of Surveillance of Drug-Resistant Tuberculosis: Achievements, Challenges, and Way Forward. The Lancet Infectious Diseases, 22, E191-E196. [Google Scholar] [CrossRef] 
[6] World Health Oranizaion (2022) WHO Operational Handbook on Tuberculosis: Module 4: Treatment—Drug-Resistant Tuberculosis Treatment. Geneva.
https://www.who.int/publications/i/item/9789240065116
[7] Azevedo-Pereira, J.M., Pires, D., Calado, M., et al. (2023) HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an ‘Emerging Syndemic’. Microorganisms, 11, Article 853. [Google Scholar] [CrossRef] [PubMed]
[8] 阿佳, 白玛郎甲. 藏医对勒塞(结核性脑膜炎)的认识与治疗[J]. 中国民族医药杂志, 2015, 21(1): 65-66.
[9] 宇妥∙元丹贡布. 四部医典[M]. 上海: 上海科学技术出版社, 1987.
[10] 包桂兰, 敖登其木格. 关于蒙藏医结核病名称的简述兼杂谈蒙医药的部分内容[J]. 世界最新医学信息文摘, 2015(14): 34.
[11] Magani, S.K.J., Mupparthi, S.D., Gollapalli, B.P., et al. (2020) Salidroside—Can It Be a Multifunctional Drug? Current Drug Metabolism, 21, 512-524. [Google Scholar] [CrossRef] [PubMed]
[12] 宗玉英, 欧阳嘉慧, 陈超扬, 等. 常用中藏药体外抗结核分枝杆菌的筛选实验[J]. 中国中药杂志, 2008, 33(24): 2973-2980.
[13] Zhang, X., He, D., Jia, J., et al. (2022) Erythropoietin Mediates Re-Programming of Endotoxin-Tolerant Macrophages through PI3K/AKT Signaling and Protects Mice against Secondary Infection. Frontiers in Immunology, 13, Article 938944. [Google Scholar] [CrossRef] [PubMed]
[14] He, S., Fan, H., Sun, B., et al. (2022) Tibetan Medicine Salidroside Improves Host Anti-Mycobacterial Response by Boosting Inflammatory Cytokine Production in Zebrafish. Frontiers in Pharmacology, 13, Article 936295. [Google Scholar] [CrossRef] [PubMed]
[15] Meng, L., Liao, X., Wang, Y., et al. (2022) Pharmacologic Therapies of ARDS: From Natural Herb to Nanomedicine. Frontiers in Pharmacology, 13, Article 930593. [Google Scholar] [CrossRef] [PubMed]
[16] Li, Y., Li, F., Zheng, T.T., et al. (2021) Lamiophlomis Herba: A Comprehensive Overview of Its Chemical Constituents, Pharmacology, Clinical Applications, and Quality Control. Biomedicine & Pharmacotherapy, 144, Article ID: 112299. [Google Scholar] [CrossRef] [PubMed]
[17] Zhuang, P., Ji, H., Li, Y. and Guo, P. (2009) In Vitro and in Vivo Anti-Inflammatory Activity of Lamiophlomis Rotate Injection. Chinese Journal of Natural Medicines, 7, 60-64. [Google Scholar] [CrossRef] 
[18] 张燕飞, 陈瑞鑫, 袁茂华, 等. 藏药独一味抗类风湿关节炎的作用及其药效物质基础研究[J]. 中国药房, 2021, 32(5): 578-583.
[19] 杨晓敏, 董德琼, 杨渝浩. 藏药独一味对肺结核患者Th1/Th2平衡调节作用的研究[J]. 遵义医学院学报, 2006, 29(1): 28-30.
[20] 杨峥嵘. 胸腺因子D和独一味对耐多药肺结核疗效的影响[J]. 中华临床新医学, 2003, 3(1): 52-52.
[21] 杨雁. 诃子化学成分、生物活性及分析方法研究进展[J]. 西藏科技, 2016(9): 34-39.
[22] Aher, V. and Wahi, A. (2011) Immunomodulatory Activity of Alcohol Extract of Terminalia chebula Retz Combretaceae. Tropical Journal of Pharmaceutical Research, 10, Article 5. [Google Scholar] [CrossRef] 
[23] Lee, H.H., Paudel, K.R., and Kim, D.W. (2015) Terminalia chebula Fructus Inhibits Migration and Proliferation of Vascular Smooth Muscle Cells and Production of Inflammatory Mediators in RAW 264.7. Evidence-Based Complementary and Alternative Medicine, 2015, Article ID: 502182. [Google Scholar] [CrossRef] [PubMed]
[24] Poladian, N., Orujyan, D., Narinyan, W., et al. (2023) Role of NF-κB during Mycobacterium tuberculosis Infection. International Journal of Molecular Sciences, 24, Article 1772. [Google Scholar] [CrossRef] [PubMed]
[25] Das, N.D., Jung, K.H., Park, J.H., et al. (2012) Proteomic Analysis of Terminalia chebula Extract-Dependent Changes in Human Lymphoblastic T Cell Protein Expression. Journal of Medicinal Food, 15, 651-657. [Google Scholar] [CrossRef] [PubMed]
[26] Patel, K., Tyagi, C., Goyal, S., et al. (2015) Identification of Chebulinic Acid as Potent Natural Inhibitor of M. tuberculosis DNA Gyrase and Molecular Insights into Its Binding Mode of Action. Computational Biology and Chemistry, 59, 37-47. [Google Scholar] [CrossRef] [PubMed]
[27] 宋青山, 贾芳. 诃子鞣质与一线二线抗结核药物联合对耐药性结核分枝杆菌活性研究[J]. 现代职业教育, 2020(44): 86-88.
[28] 崔树婷, 刘喜平, 陈嘉慧. 湿生扁蕾药理作用研究进展[J]. 中国民族民间医药, 2020, 29(6): 37-39, 45.
[29] 王焕弟, 谭成玉, 白雪芳, 等. 藏药湿生扁蕾有效成分抑菌作用初探[J]. 天然产物研究与开发, 2005, 17(5): 598-599.
[30] Yeung, M.F., Lau, C.B.S., Chan, R.C.Y., Zong, Y. and Che, C.T. (2009) Search for Antimycobacterial Constituents from a Tibetan Medicinal Plant, Gentianopsis paludosa. Phytotherapy Research, 23, 123-125. [Google Scholar] [CrossRef] [PubMed]
[31] 米琴, 曹长年, 赵宙兴, 等. 测定湿生扁蕾有效成分对白细胞吞噬功能的影响[J]. 青海师范大学学报(自然科学版), 2004(1): 65-66.
[32] Jiménez-Arellanes, A., Luna-Herrera, J., Cornejo-Garrido, J., et al. (2013) Ursolic and Oleanolic Acids as Antimicrobial and Immunomodulatory Compounds for Tuberculosis Treatment. BMC Complementary and Alternative Medicine, 13, Article No. 258. [Google Scholar] [CrossRef] [PubMed]
[33] Singh, D.K., Tousif, S., Bhaskar, A., et al. (2021) Luteolin as a Potential Host-Directed Immunotherapy Adjunct to Isoniazid Treatment of Tuberculosis. PLOS Pathogens, 17, e1009805. [Google Scholar] [CrossRef] [PubMed]
[34] 王俊丽, 刘喜平, 崔树婷, 等. 湿生扁蕾不同提取部位对肺纤维化模型大鼠肺功能的影响[J]. 中国民族民间医药, 2022, 31(23): 21-26.
[35] 仁真旺甲, 文检, 苏永文, 等. 藏药沙棘的文献考证研究[J]. 中国民族民间医药, 2016, 25(6): 4-8.
[36] 李宇飞, 明亮, 徐林霞, 等. 三种中草药抗结核分枝杆菌作用的实验研究[J]. 山西医科大学学报, 2010, 41(7): 627-630.
[37] 刘艳霞. 20种常用藏药材抗菌活性筛选[D]: [硕士学位论文]. 拉萨: 西藏大学, 2021.
[38] Wang, H., Bi, H., Gao, T., Zhao, B., Ni, W. and Liu, J. (2018) A Homogalacturonan from Hippophae rhamnoides L. Berries Enhance Immunomodulatory Activity through TLR4/MyD88 Pathway Mediated Activation of Macrophages. International Journal of Biological Macromolecules, 107, 1039-1045. [Google Scholar] [CrossRef] [PubMed]
[39] 王蓉, 李胜男, 陈春, 等. 沙棘多糖对巨噬细胞和免疫抑制小鼠的免疫调节作用研究[J]. 中南药学, 2020, 18(3): 384-388.
[40] Seo, K., Yang, J.H., Kim, S.C., Ku, S.K., Ki, S.H. and Shin, S.M. (2014) The Antioxidant Effects of Isorhamnetin Contribute to Inhibit COX-2 Expression in Response to Inflammation: A Potential Role of HO-1. Inflammation, 37, 712-722. [Google Scholar] [CrossRef] [PubMed]
[41] Jiang, F., Guan, H., Liu, D., et al. (2017) Flavonoids from Sea Buckthorn Inhibit the Lipopolysaccharide-Induced Inflammatory Response in RAW264.7 Macrophages through the MAPK and NF-κB Pathways. Food & Function, 8, 1313-1322. [Google Scholar] [CrossRef] 
[42] 田卫花, 马兴铭, 刘英, 等. 砂生槐水提取物对免疫抑制小鼠细胞免疫功能的影响[J]. 天然产物研究与开发, 2009, 21(3): 477-479.
[43] 马兴铭, 李红玉, 王波, 等. 西藏砂生槐生物碱抑菌及杀虫活性的测定[J]. 中国生物防治, 2005, 21(3): 183-186.
[44] 陈亚玲, 任丽娟, 王丽, 等. 生物碱类化合物抗结核病的研究进展[J]. 中草药, 2020, 51(3): 799-805.
[45] 王国玺, 赵伟栋, 陈玉文, 等. 12种藏医常用药材抗结核分枝杆菌活性筛选[J]. 医学信息, 2014(13): 86.
[46] 刘艳霞, 任明辉, 杜宝中. 基于网络药理学的白头翁治疗肺结核作用机制研究[J]. 中国当代医药, 2021, 28(27): 4-9.
[47] 王淑英, 王晓兰, 刘萌萌, 等. 白头翁提取物体外抗结核杆菌作用的实验研究[J]. 时珍国医国药, 2011, 22(12): 2965-2966.
[48] 龙慧珍, 周晓蕾. 回生甘露丸联合乙胺吡嗪利福异烟治疗初期肺结核的临床研究[J]. 现代药物与临床, 2021, 36(10): 2093-2097.
[49] 李云鹏. 回生甘露丸对肺结核继发性纤维化患者血清炎性因子及纤维化指标的影响分析[J]. 西南军医, 2018, 20(5): 555-557.
[50] 童丽, 热增才旦, 袁冬平, 等. 四味藏木香汤散临床应用概述[J]. 中国民族民间医药, 2015, 24(17): 4-5.
[51] 红梅, 陈秋红, 王志瑾, 等. 藏药经典验方“玛奴西汤”颗粒免疫调节作用的实验研究[J]. 中国医药导报, 2012, 9(35): 50-51.
[52] 刘博学. 藏木香的抗结核病机理研究[D]: [硕士学位论文]. 西宁: 青海大学, 2021.
[53] Tosun, F., Akyüz Kızılay, Ç., Şener, B. and Vural, M. (2005) The Evaluation of Plants from Turkey for in Vitro. Antimycobacterial Activity. Pharmaceutical Biology, 43, 58-63. [Google Scholar] [CrossRef] 
[54] Zhang, Q., Jiang, X., He, W., Wei, K., Sun, J., Qin, X., Zheng, Y. and Jiang, X. (2017) MCL Plays an Anti-Inflammatory Role in Mycobacterium tuberculosis-Induced Immune Response by Inhibiting NF-κB and NLRP3 Inflammasome Activation. Mediators of Inflammation, 2017, Article ID: 2432904. [Google Scholar] [CrossRef] [PubMed]
[55] 更藏东智, 卡毛才让. 藏医联合西医治疗复治涂阳肺结核的临床效果[J]. 健康大视野, 2021(22): 32.
[56] 郝春燕, 高晓明, 周璞, 等. 紫草加减方保留灌肠联合抗结核药物对结核性腹膜炎患者临床疗效及腹水血清ADA、CA125、PCT水平影响[J]. 辽宁中医药大学学报, 2019, 21(10): 164-167.
[57] 李秀萍, 王玲, 王馨, 等. 紫草素调节结核分枝杆菌诱导THP-1细胞炎症反应的机制研究[J]. 解放军医药杂志, 2021, 33(10): 104-108.
[58] 李晓朋, 史志龙, 龚普阳, 等. 基于网络药理学的藏药二十五味肺病丸防治新冠病毒肺炎(COVID-19)可行性分析及机制探讨[J]. 世界科学技术-中医药现代化, 2021, 23(4): 1086-1095.
[59] 仁桑. 藏药仁青常觉治疗结核性胸膜炎观察[J]. 中国民族医药杂志, 2013, 19(12): 21-22.

为你推荐